IONS FY 2024 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IONSIonis Pharmaceuticals, Inc.

$13B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$705M-10.5% YoY

Gross Profit

$694M98.4% margin

Operating Income

-$475M-67.4% margin

Net Income

-$454M-64.4% margin

EPS (Diluted)

$-3.04

Cash Flow

Operating Cash Flow

-$501M

Free Cash Flow

-$546M

Stock-Based Comp.

$130M

Balance Sheet

Total Assets

$3.0B

Total Liabilities

$2.4B

Stockholders' Equity

$588M

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$705M	$788M	-10.5%
Gross Profit	$694M	$779M	-10.9%
Operating Income	-$475M	-$354M	-34.3%
Net Income	-$454M	-$366M	-23.9%